These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19710548)

  • 1. Impact of comorbidities on the management of psoriasis.
    Gerdes S; Mrowietz U
    Curr Probl Dermatol; 2009; 38():21-36. PubMed ID: 19710548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidities in psoriasis.
    Aurangabadkar SJ
    Indian J Dermatol Venereol Leprol; 2013 Jul; 79 Suppl 7():S10-7. PubMed ID: 23974690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing comorbidities in psoriasis.
    Boehncke WH; Boehncke S
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():22-7. PubMed ID: 20096158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidities in psoriasis patients.
    Kim N; Thrash B; Menter A
    Semin Cutan Med Surg; 2010 Mar; 29(1):10-5. PubMed ID: 20430302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities].
    Daudén E; Castañeda S; Suárez C; García-Campayo J; Blasco AJ; Aguilar MD; Ferrándiz C; Puig L; Sánchez-Carazo JL;
    Actas Dermosifiliogr; 2012 Jan; 103 Suppl 1():1-64. PubMed ID: 22364603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cardiovascular disorders in psoriasis patients: current and future.
    Tablazon IL; Al-Dabagh A; Davis SA; Feldman SR
    Am J Clin Dermatol; 2013 Feb; 14(1):1-7. PubMed ID: 23329076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe psoriasis: beyond the skin, what are the risks of not treating the disease?].
    Bessis D
    Ann Dermatol Venereol; 2008 Jul; 135 Suppl 5():S285-9. PubMed ID: 18721666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psoriasis, metabolic syndrome and its components].
    Ortonne JP
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 4():S235-42. PubMed ID: 18466790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis in patients with psoriasis.
    Gulliver W
    Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiometabolic comorbidities and the approach to patients with psoriasis.
    Gisondi P; Girolomoni G
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():14-21. PubMed ID: 20096157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Position statement for the management of comorbidities in psoriasis.
    Dauden E; Blasco AJ; Bonanad C; Botella R; Carrascosa JM; González-Parra E; Jodar E; Joven B; Lázaro P; Olveira A; Quintero J; Rivera R
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2058-2073. PubMed ID: 29992631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoriasis as a cardiovascular risk factor: updates and algorithmic approach.
    Cozzani E; Rosa GM; Burlando M; Parodi A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):659-665. PubMed ID: 29683293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acupuncture as a Complementary Method of Traditional Psoriasis Treatment: Myth or Reality?
    Mahović D; Mrsić F
    Acta Dermatovenerol Croat; 2016 Aug; 24(3):221-2. PubMed ID: 27663925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.